Last year, we discussed how artificial intelligence (AI) could be used to enhance autoimmune disease prediction and treatments through an algorithm called EXPRESSO—EXpression PREdiction with Summary Statistics Only—developed by a research team at Penn State College of Medicine. Penn State researchers have developed a new AI method to predict autoimmune disease progression.

Psoriasis is known to be a chronic skin condition, but it can also result in inflammation of the joints. Previous research also shows that Crohn's disease is one of the top comorbidities in psoriasis patients, but the reasoning behind this was unknown. However, new research at Uppsala University in Sweden could explain why those diagnosed with psoriasis are more prone to gastrointestinal problems.

The University of Toledo's College of Medicine and Life Sciences has made a groundbreaking discovery regarding the treatment of rheumatoid arthritis (RA), a possible treatment that helps suppress inflammatory cells while increasing anti-inflammatory responses.

Working with data from the National Institutes of Health’s (NIH’s) All of Us Program, the Autoimmune Registry aims to transform how patients with autoimmune diseases understand and manage their health, providing them with critical insights that could lead to more personalized care and improved health outcomes.

This year, the Autoimmune Registry has continued to work towards reducing the time of diagnosis, supporting autoimmune research, computing prevalence statistics, and establishing autoimmune disease as a major disease class.

Autoimmune diseases can arise from a combination of genetic factors and environmental triggers. Increasingly, research has focused on the role of environmental exposures, particularly air pollution, in developing these conditions.

Researchers hypothesized that there may be a hereditary risk for autoimmune diseases in women with primary ovarian insufficiency (POI). A recent study in The Journal of Clinical Endocrinology & Metabolism examined the link between autoimmune diseases and POI using the electronic health records of 610 women diagnosed with POI as well as their close relatives.

Receiving a misdiagnosis or having symptoms dismissed by healthcare providers are common experiences for people with autoimmune diseases.

Last year, we discussed how those diagnosed with vitiligo have a higher chance of having another autoimmune disease. However, recent research shows that there may be a correlation between vitiligo and hearing loss.

Our mission at the Autoimmune Registry is to establish autoimmune disease as a major class of disease through supporting research in hopes of reducing the time of diagnosis, gaining the attention of healthcare providers, and improving existing treatment protocols.

Based on a mouse model study, researchers at Emory University reveal a family of enzymes, particularly one called CU43, that can reduce the impact of these harmful antibodies in diseases like MG.

Every month, Autoimmune Registry hosts a webinar with our PAG members to provide them with a platform to present new research, innovations, and knowledge on autoimmune diseases. On October 23rd from 12-1 pm Eastern, our new Network member, Own MG, will have a presentation on understanding Myasthenia Gravis.

Autoimmune diseases are often thought of as diseases affecting adults and the elderly. However, there are various autoimmune diseases that can begin in childhood, such as juvenile idiopathic arthritis and juvenile dermatomyositis.

Autoimmune Registry is hosting a webinar on October 7th, 2024, at 4:00 pm EST to discuss new technologies used in autoimmune disease clinical trials. We wanted to take this time to introduce one of our presenters, Dr. Mamatha Pasnoor!

Autoimmune Registry is hosting a webinar on October 7th, 2024, at 4:00 pm EST to discuss new technologies used in autoimmune disease clinical trials. We wanted to take this time to introduce one of our presenters, Dr. Mazen M. Dimachkie!

Here at the Autoimmune Registry, we believe that sharing stories is important for bringing awareness to autoimmune diseases. The story below is from one of our registrants, Emily, who kindly allowed us to share her story.

This past June, a team of international researchers, led by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), uncovered a novel mechanism by which myositis autoantibodies contribute to disease progression.